3 Neurofibromatosis Clinical Trials in Indianapolis, IN (2026)

Q: How do I join a clinical trial in Indianapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you.

Recruiting Neurofibromatosis Studies in Indianapolis

NCT06188741Recruiting

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

Plexiform neurofibromas (PN) are known to cause significant morbidity in children with NF1. The recent FDA approval for selumetinib in children 2 years and older with inoperable symptomatic PN was bas...

Indianapolis, INPHASE2200 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06502171Recruiting

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

Based on the clinical activity of both selumetinib and cabozantinib as monotherapies in clinical trials, the demonstrated activity of these agents in reduced doses in preclinical studies, and the non-...

Indianapolis, INPHASE130 participantsGirish Dhall, MD

View Study Details

NCT06541847Recruiting

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

The trial will be an open label, single arm, phase 2 study in 20 participants. The study will assess the tolerability and efficacy of HLX-1502 in participants with NF1 16 years of age or older with pr...

Indianapolis, INPHASE225 participantsHealx Limited

View Study Details

About Neurofibromatosis Clinical Trials in Indianapolis

Neurofibromatosis is a group of genetic conditions that cause tumors to grow on nerve tissue. NF1 is the most common type, causing skin changes and bone deformities. Treatment includes monitoring, surgery for problematic tumors, and MEK inhibitors for plexiform neurofibromas.

There are currently 3 neurofibromatosis clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 255 participants. Research is being sponsored by University of Alabama at Birmingham, Girish Dhall, MD, Healx Limited. Clinical trial participation is free and participants receive study-related medical care at no cost.

Neurofibromatosis Clinical Trials in Indianapolis — FAQ

Are there neurofibromatosis clinical trials in Indianapolis?

Yes, there are 3 neurofibromatosis clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What neurofibromatosis treatments are being tested?

The 3 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for neurofibromatosis.

Data updated October 16, 2026 from ClinicalTrials.gov